Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Rheumatology

Clinical Pharmacology

Long-term follow-up and optimization of infliximab in refractory uveitis due to Behcet disease: National study of 103 white patients

The Journal of Rheumatology | May 05, 2021 Clinical Pharmacology

Immunosuppressive therapy withdrawal after remission achievement in patients with lupus nephritis

Rheumatology | May 01, 2021 Clinical Pharmacology

Real-world experience on omalizumab treatment for patients with normocomplementemic urticarial vasculitis

Journal of Asthma and Allergy | Apr 28, 2021 Clinical Pharmacology

Long-term tolerability and efficacy of golimumab in active non-radiographic axial spondyloarthritis: Results from open-label extension

Rheumatology | Apr 24, 2021 Clinical Pharmacology

Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis

Arthritis Research & Therapy | Apr 22, 2021 Clinical Pharmacology

Risk of COVID-19 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional DMARDs in Italy

Rheumatology | Apr 19, 2021 Clinical Pharmacology

Hydroxychloroquine prophylaxis for preeclampsia, hypertension and prematurity in pregnant patients with systemic lupus erythematosus: A meta-analysis

Lupus | Apr 19, 2021 Clinical Pharmacology

Efficacy of methotrexate in reducing the risk of bone erosion in patients with rheumatoid arthritis: A systematic review of randomized controlled trials

Osteoporosis International | Apr 17, 2021 Clinical Pharmacology

Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial

Annals of Rheumatic Diseases | Apr 13, 2021 Clinical Pharmacology

Trial of upadacitinib and adalimumab for psoriatic arthritis

New England Journal of Medicine | Apr 07, 2021 Clinical Pharmacology

« Prev 1 … 13 14 15 16 17 … 82 Next »

Long-term follow-up and optimization of infliximab in refractory uveitis due to Behcet disease: National study of 103 white patients

Immunosuppressive therapy withdrawal after remission achievement in patients with lupus nephritis

Real-world experience on omalizumab treatment for patients with normocomplementemic urticarial vasculitis

Long-term tolerability and efficacy of golimumab in active non-radiographic axial spondyloarthritis: Results from open-label extension

Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis

Risk of COVID-19 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional DMARDs in Italy

Hydroxychloroquine prophylaxis for preeclampsia, hypertension and prematurity in pregnant patients with systemic lupus erythematosus: A meta-analysis

Efficacy of methotrexate in reducing the risk of bone erosion in patients with rheumatoid arthritis: A systematic review of randomized controlled trials

Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial

Trial of upadacitinib and adalimumab for psoriatic arthritis

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Pulmonary Embolism: MCQs Challenge

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

Top Foods to Combat Winter Illness

Long-term follow-up and optimization of infliximab in refractory uveitis due to Behcet disease: National study of 103 white patients

Immunosuppressive therapy withdrawal after remission achievement in patients with lupus nephritis

Real-world experience on omalizumab treatment for patients with normocomplementemic urticarial vasculitis

Long-term tolerability and efficacy of golimumab in active non-radiographic axial spondyloarthritis: Results from open-label extension

Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis

Risk of COVID-19 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional DMARDs in Italy

Hydroxychloroquine prophylaxis for preeclampsia, hypertension and prematurity in pregnant patients with systemic lupus erythematosus: A meta-analysis

Efficacy of methotrexate in reducing the risk of bone erosion in patients with rheumatoid arthritis: A systematic review of randomized controlled trials

Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial

Trial of upadacitinib and adalimumab for psoriatic arthritis

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Pulmonary Embolism: MCQs Challenge

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

Top Foods to Combat Winter Illness

Select Specialty

Select Topic